Dr. Ashwath Jayagopal
Equibles does not estimate personal net worth.
About Dr. Ashwath Jayagopal
Opus Genetics, Inc. reported in an 8-K filed October 21, 2026 that Dr. Ashwath Jayagopal was terminated as Chief Scientific and Development Officer, effective October 19, 2026. The proxy statement of Opus Genetics, Inc. reports total compensation of $764,848 for Dr. Ashwath Jayagopal in fiscal 2025, including a base salary of $416,000. Disclosed compensation is on record for 2 fiscal years.
“Opus Genetics, Inc. (the “Company”) and Ashwath Jayagopal have agreed that Dr. Jayagopal will transition from his role as the Company’s Chief Scientific and Development Officer, effective as of October 19, 2026 (the “Separation Date”).”
Affiliation history
-
Opus Genetics, Inc. (IRD)
Proxy statement
Start not stated–2026-10-19
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Opus Genetics, Inc. (IRD) | Chief Scientific and Development Officer | $416,000 | $764,848 |
| 2024 | Opus Genetics, Inc. (IRD) | Chief Scientific and Development Officer | $354,023 | $1,242,154 |